Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts.

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,240 · see citing works

Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction

Chomczyński, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 47,092 · see citing works

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444 · see citing works

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439 · see citing works

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130 · see citing works

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224 · see citing works

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.

Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290 · see citing works

Principles of Bone Biology

(2019) · Elsevier eBooks · doi:10.1016/c2015-1-01622-2 · Cited by 1,690 · see citing works

Principles of Bone Biology

Compston, J. E. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2431019.x · Cited by 1,383 · see citing works

Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i>¹

Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.-I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.3.5837 · Cited by 1,201 · see citing works

TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T Cells

Wong, B. R., Rho, J., Arron, J. R., Robinson, E. A., Orlinick, J. R., Chao, M. V., Kalachikov, S. M., Cayani, E., Bartlett, F. S., Frankel, W. N., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25190 · Cited by 1,042 · see citing works

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis.

Tsuda, E., Goto, M., Mochizuki, S.-I., Yano, K., Kobayashi, F., Morinaga, T., & Higashio, K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6603 · Cited by 787 · see citing works

Estrogen Inhibits Bone Resorption by Directly Inducing Apoptosis of the Bone-resorbing Osteoclasts

Kameda, T., Mano, H., Yuasa, T., Mori, Y., Miyazawa, K., Shiokawa, M., Nakamaru, Y., 広井, 恵., Hiura, K., Kameda, A., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.4.489 · Cited by 519 · see citing works

Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro

Lakkakorpi, P. T., & Väänänen, K. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060806 · Cited by 248 · see citing works

Identification of osteopontin in isolated rabbit osteoclasts

Tezuka, K.-I., Sato, T., Kamioka, H., Nijweide, P. J., Tanaka, K., Matsuo, T., Ohta, M., Kurihara, N., Hakeda, Y., & Kumegawa, M. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90832-6 · Cited by 209 · see citing works

Immunocytochemical distribution of extracellular matrix receptors in human osteoclasts: A β3 integrin is colocalized with vinculin and talin in the podosomes of osteoclastoma giant cells

Zambonin-Zallone, A., Teti, A. M., Grano, M., Rubinacci, A., Abbadini, M., Gaboli, M. P., & Marchisio, P. C. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90266-8 · Cited by 201 · see citing works

Characterization of Structural Domains of Human Osteoclastogenesis Inhibitory Factor

Yamaguchi, K., Kinosaki, M., Goto, M., Kobayashi, F., Tsuda, E., Morinaga, T., & Higashio, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.5117 · Cited by 200 · see citing works

Parathyroid hormone induces sequential c-fos expression in bone cells in vivo: in situ localization of its receptor and c-fos messenger ribonucleic acids

Lee, K. (1994) · Endocrinology · doi:10.1210/en.134.1.441 · Cited by 183 · see citing works

Parathyroid hormone induces sequential c-fos expression in bone cells in vivo: in situ localization of its receptor and c-fos messenger ribonucleic acids.

Lee, K., Deeds, J. D., Chiba, S., UN-NO, M., Bond, A., & Segre, G. V. (1994) · Endocrinology · doi:10.1210/endo.134.1.8275957 · Cited by 135 · see citing works

Calcitonin-induced changes in the cytoskeleton are mediated by a signal pathway associated with protein kinase A in osteoclasts

Suzuki, H., Nakamura, I., Takahashi, N., Ikuhara, T., Matsuzaki, K., Isogai, Y., Hori, M., & Suda, T. (1996) · Endocrinology · doi:10.1210/endo.137.11.8895334 · Cited by 114 · see citing works

Mammalian Mature Osteoclasts as Estrogen Target Cells

Mano, H., Yuasa, T., Kameda, T., Miyazawa, K., Nakamaru, Y., Shiokawa, M., Mori, Y., Yamada, T., Miyata, K., Shindo, H., et al. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0947 · Cited by 97 · see citing works

A simple method to assess osteoclast-mediated bone resorption using unfractionated bone cells

Takada, Y., Kusuda, M., Hiura, K., Sato, T., Mochizuki, H., Nagao, Y., Tomura, M., YAHIRO, M., Hakeda, Y., KAWASHIMA, H., et al. (1992) · Bone and Mineral · doi:10.1016/0169-6009(92)90785-c · Cited by 97 · see citing works

Vitamin D and the hematolymphopoietic tissue: a 1994 update.

Manolagas, S. C., Yu, X., Girasole, G., & Bellido, T. (1994) · PubMed · Cited by 96 · see citing works

Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor.

Tomoyasu, A., Goto, M., Fujise, N., Mochizuki, S.-I., Yasuda, H., Morinaga, T., Tsuda, E., & Higashio, K. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8443 · Cited by 83 · see citing works

Detection and Characterization of Apoptosis in Osteoclasts in Vitro

Kameda, T., Ishikawa, H., & Tsutsui, T. W. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1251 · Cited by 62 · see citing works

Colony Stimulating Factor-1–Induced Osteoclast Spreading Depends on Substrate and Requires the Vitronectin Receptor and the c-src Proto-Oncogene

Teti, A. M., Taranta, A., Migliaccio, S., Degiorgi, A., Santandrea, E., Villanova, I., Faraggiana, T., Chellaiah, M., & Hruska, K. A. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.1.50 · Cited by 43 · see citing works

Isolation of highly enriched rabbit osteoclasts from collagen gels: A new assay system for bone-resorbing activity of mature osteoclasts

Kakudo, S., Miyazawa, K., Kameda, T., Mano, H., Mori, Y., Yuasa, T., Nakamaru, Y., Shiokawa, M., Nagahira, K., Tokunaga, S., et al. (1996) · Journal of Bone and Mineral Metabolism · doi:10.1007/bf02239480 · Cited by 43 · see citing works

The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone Resorption

Hofbauer, L. C., Khosla, S., Dunstan, C. R., Lacey, D. L., Boyle, W. J., & Riggs, B. L. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.1.2 · Cited by 1,167 · see citing works

IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology

Tat, S. K., Marc, P., Théoleyre, S., Heymann, D., & Fortun, Y. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.10.005 · Cited by 959 · see citing works

Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease

Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824 · see citing works

Biology of the RANKL–RANK–OPG System in Immunity, Bone, and Beyond

Walsh, M. C., & Choi, Y. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00511 · Cited by 599 · see citing works

Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology

Hofbauer, L. C., & Heufelder, A. E. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100226 · Cited by 586 · see citing works

Cell biology of the osteoclast

Roodman, G. D. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00061-2 · Cited by 570 · see citing works

The effect of a single dose of osteoprotegerin in postmenopausal women.

Bekker, P. J., Holloway, D., Nakanishi, A., Arrighi, M., Leese, P. T., & Dunstan, C. R. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.2.348 · Cited by 484 · see citing works

Gene Expression of Osteoclast Differentiation Factor Is Induced by Lipopolysaccharide in Mouse Osteoblasts Via Toll-Like Receptors1

Kikuchi, T., Matsuguchi, T., Tsuboi, N., Mitani, A., Tanaka, S., Matsuoka, M., Yamamoto, G., Hishikawa, T., Noguchi, T., & Yoshikai, Y. (2001) · Journal of Immunology · doi:10.4049/jimmunol.166.5.3574 · Cited by 265 · see citing works

Transforming Growth Factor β Affects Osteoclast Differentiation via Direct and Indirect Actions

Quinn, J. M. W., Itoh, K., Udagawa, N., Häusler, K., Yasuda, H., Shima, N., Mizuno, A., Higashio, K., Takahashi, N., Suda, T., et al. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.10.1787 · Cited by 278 · see citing works

Biology of the TRANCE axis

Walsh, M. C., & Choi, Y. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00027-3 · Cited by 199 · see citing works

Increased frequency ofATM mutations in breast carcinoma patients with early onset disease and positive family history

Teraoka, S. N., Malone, K. E., Doody, D. R., Suter, N. M., Ostrander, E. A., Daling, J. R., & CONCANNON, P. J. (2001) · Cancer · doi:10.1002/1097-0142(20010801)92:3 · Cited by 111 · see citing works

The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis

Haynes, D. R., Crotti, T. N., Potter, A. E., Loric, M., Atkins, G. J., Howie, D. W., & Findlay, D. M. (2001) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.83b6.10905 · Cited by 186 · see citing works

The Osteoblast-specific Transcription Factor Cbfa1 Contributes to the Expression of Osteoprotegerin, a Potent Inhibitor of Osteoclast Differentiation and Function

Thirunavukkarasu, K., Halladay, D., Miles, R. R., Yang, X., Galvin, R. J. S., Chandrasekhar, S., Martin, T. J., & Onyia, J. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000322200 · Cited by 181 · see citing works

Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure

Kazama, J. J., Shigematsu, T., Yano, K., Tsuda, E., Miura, M., Iwasaki, Y., Kawaguchi, Y., Gejyo, F., Kurokawa, K., & Fukagawa, M. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.31402 · Cited by 169 · see citing works

The Role of Receptor Activator of Nuclear Factor- B Ligand and Osteoprotegerin in the Pathogenesis and Treatment of Metabolic Bone Diseases

Hofbauer, L. C., & Heufelder, A. E. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6702 · Cited by 175 · see citing works

RANKL protein is expressed at the pannus–bone interface at sites of articular bone erosion in rheumatoid arthritis

Pettit, A. R., Walsh, N. C., Manning, C., Goldring, S. R., & Gravallese, E. M. (2006) · Rheumatology · doi:10.1093/rheumatology/kel045 · Cited by 151 · see citing works

Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha

Wada, N., Maeda, H., Yoshimine, Y., & Akamine, A. (2004) · Bone · doi:10.1016/j.bone.2004.04.023 · Cited by 145 · see citing works

Stimulation of Osteoprotegerin (OPG) Gene Expression by Transforming Growth Factor-β (TGF-β)

Thirunavukkarasu, K., Miles, R. R., Halladay, D., Yang, X., Galvin, R. J. S., Chandrasekhar, S., Martin, T. J., & Onyia, J. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104319200 · Cited by 138 · see citing works

The Bone Organ System

Lee, C. A., & Einhorn, T. A. (2001) · Elsevier eBooks · doi:10.1016/b978-012470862-4/50002-7 · Cited by 135 · see citing works

Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism

Hofbauer, L. C. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410195 · Cited by 120 · see citing works

Osteoclast formation and resorption

Lerner, U. H. (2000) · Matrix Biology · doi:10.1016/s0945-053x(00)00052-4 · Cited by 114 · see citing works

New Perspective in Osteoarthritis: The OPG and RANKL System as a Potential Therapeutic Target?

Tat, S. K., Pelletier, J.-P., Velasco, C. R., Padrines, M., & Martel-Pelletier, J. (2009) · The Keio Journal of Medicine · doi:10.2302/kjm.58.29 · Cited by 112 · see citing works

Osteoprotegerin in the Inner Ear May Inhibit Bone Remodeling in the Otic Capsule

Zehnder, A. F., Kristiansen, A. G., Adams, J. C., Merchant, S. N., & McKenna, M. J. (2005) · The Laryngoscope · doi:10.1097/01.mlg.0000150702.28451.35 · Cited by 112 · see citing works

Sequence Variations in the Osteoprotegerin Gene Promoter in Patients with Postmenopausal Osteoporosis

Arko, B., Preželj, J., Komel, R., Kocijancic, A., Hudler, P., & Marc, J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020124 · Cited by 105 · see citing works

Transcriptional Mechanisms of Bone Morphogenetic Protein-induced Osteoprotegrin Gene Expression

Wan, M., Shi, X., Feng, X., & Cao, X. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006918200 · Cited by 104 · see citing works

Sustained antiresorptive effects after a single treatment with human recombinant osteoprotegerin (OPG): a pharmacodynamic and pharmacokinetic analysis in rats.

Capparelli, C., Morony, S., Warmington, K., Adamu, S., Lacey, D., Dunstan, C. R., Stouch, B., Martin, S., & Kostenuik, P. J. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.5.852 · Cited by 103 · see citing works

Dexamethasone promotes osteoclastogenesis by inhibiting osteoprotegerin through multiple levels

Kondo, T., Kitazawa, R., Yamaguchi, A., & Kitazawa, S. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21414 · Cited by 103 · see citing works

Regulation of osteoclast activity

Greenfield, E. M., Bi, Y., & Miyauchi, A. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00156-3 · Cited by 97 · see citing works

Age-Related Decline in Osteoprotegerin Expression by Human Bone Marrow Cells Cultured in Three-Dimensional Collagen Sponges

Makhluf, H. A., Mueller, S. M., Mizuno, S., & Glowacki, J. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2182 · Cited by 96 · see citing works

Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: Role in the interactions with receptor activator of nuclear factor κB ligand (RANKL) and RANK

Théoleyre, S., Tat, S. K., Vusio, P., Blanchard, F., Gallagher, J. T., Ricard‐Blum, S., Fortun, Y., Padrines, M., Rédiní, F., & Heymann, D. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.06.120 · Cited by 94 · see citing works

High serum osteoprotegerin and low RANKL in primary biliary cirrhosis

Szalay, F., Hegedüs, D., Lakatos, P. L., Tornai, I., Bajnok, É., Dunkel, K., & Lakatos, P. L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00435-x · Cited by 91 · see citing works

Inhibitory effect of Zn2+ in zinc‐containing β‐tricalcium phosphate on resorbing activity of mature osteoclasts

Yamada, Y., Ito, A., Kojima, H., Sakane, M., Miyakawa, S., Uemura, T., & LeGeros, R. Z. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31265 · Cited by 76 · see citing works

1α,25 Dihydroxyvitamin D3 Rapidly Regulates the Mouse Osteoprotegerin Gene Through Dual Pathways

Kondo, T., Kitazawa, R., Maeda, S., & Kitazawa, S. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040604 · Cited by 76 · see citing works

A Novel Osteoblast-derived C-type Lectin That Inhibits Osteoclast Formation

Zhou, H., Kartsogiannis, V., Hu, Y. S., Elliott, J., Quinn, J. M. W., McKinstry, W. J., Gillespie, M. T., & Ng, K. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011554200 · Cited by 74 · see citing works

Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women

Arko, B., Preželj, J., Kocijančič, A., Komel, R., & Marc, J. (2004) · Maturitas · doi:10.1016/j.maturitas.2004.08.006 · Cited by 71 · see citing works

Withaferin-A, a steroidal lactone encapsulated mannose decorated liposomes ameliorates rheumatoid arthritis by intriguing the macrophage repolarization in adjuvant-induced arthritic rats

Sultana, F., Neog, M. K., & Rasool, M. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.04.046 · Cited by 63 · see citing works

Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status.

Fahrleitner-Pammer, A., Dobnig, H., Piswanger-Soelkner, C., Bonelli, C., Dimai, H.-P., Leb, G., & Obermayer-Pietsch, B. (2003) · Wiener Klinische Wochenschrift · doi:10.1007/bf03040334 · Cited by 62 · see citing works

Osteoprotegerin differentially regulates protease expression in osteoclast cultures

Wittrant, Y., Couillaud, S., Théoleyre, S., Dunstan, C. R., Heymann, D., & Rédiní, F. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00179-1 · Cited by 61 · see citing works

Role of the RANK/RANKL pathway in breast cancer

Kiesel, L., & Kohl, A. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.01.001 · Cited by 61 · see citing works

Cytokines and Bone Remodeling

Mundy, G. R., Oyajobi, B. O., Gutierrez, G. E., Sterling, J. A. R., Padalecki, S. S., Elefteriou, F., & Zhao, M. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50020-3 · Cited by 59 · see citing works

Antiosteoporosis Effects, Pharmacokinetics, and Drug Delivery Systems of Icaritin: Advances and Prospects

Gao, L., & Zhang, S. (2022) · Pharmaceuticals · doi:10.3390/ph15040397 · Cited by 58 · see citing works

Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men

Yamada, Y. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00125-2 · Cited by 57 · see citing works

Tissue Inhibitor of Metalloproteinases 1 and 2 Directly Stimulate the Bone-Resorbing Activity of Isolated Mature Osteoclasts

Sobue, T., Hakeda, Y., Kobayashi, Y., Hayakawa, H., Yamashita, K., Aoki, T., Kumegawa, M., Noguchi, T., & Hayakawa, T. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.12.2205 · Cited by 57 · see citing works

Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis

Bolon, B. N., Shalhoub, V., Kostenuik, P. J., Campagnuolo, G., Morony, S., Boyle, W. J., Zack, D. J., & Feige, U. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10680 · Cited by 57 · see citing works

Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities

Wittrant, Y., Théoleyre, S., Couillaud, S., Dunstan, C. R., Heymann, D., & Rédiní, F. (2003) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.10.016 · Cited by 55 · see citing works

Osteoprotegerin is produced when prostaglandin synthesis is inhibited causing osteoclasts to detach from the surface of mouse parietal bone and attach to the endocranial membrane

O’Brien, E. A., Williams, J. H. H., & Marshall, M. J. E. (2001) · Bone · doi:10.1016/s8756-3282(00)00431-2 · Cited by 54 · see citing works

Proliferation and gene expression of osteoblasts cultured in DMEM containing the ionic products of dicalcium silicate coating

Sun, J., Li, J., Liu, X., Wei, L., Wang, G., & Meng, F. (2009) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2009.01.007 · Cited by 51 · see citing works

Cellular activity and signaling induced by osteoprotegerin in osteoclasts: involvement of receptor activator of nuclear factor κB ligand and MAPK

Théoleyre, S., Wittrant, Y., Couillaud, S., Vusio, P., Berreur, M., Dunstan, C. R., Blanchard, F., Rédiní, F., & Heymann, D. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.10.005 · Cited by 49 · see citing works

Receptor Activator for Nuclear Factor Kappab Ligand and Osteoprotegerin: Regulators of Bone Physiology and Immune Responses/Potential Therapeutic Agents and Biochemical Markers

Buckley, K. A., & Fraser, W. D. (2002) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456320203900602 · Cited by 45 · see citing works

Effects of cod bone gelatin on bone metabolism and bone microarchitecture in ovariectomized rats.

Han, X., Xu, Y.-J., Wang, J.-B., Pei, X.-R., Yang, R.-Y., Li, N., & Li, Y. (2009) · Bone · doi:10.1016/j.bone.2008.12.005 · Cited by 41 · see citing works

The TNF Receptor Superfamily: Role in Immune Inflammation and Bone Formation

Cheng, X., Kinosaki, M., Murali, R., & Greene, M. I. (2003) · Immunologic Research · doi:10.1385/ir:27:2-3:287 · Cited by 42 · see citing works

Retardation in Bone Resorption after Bone Marrow Ablation in Klotho Mutant Mice1

Yamashita, T., Yoshitake, H., Tsuji, K., Kawaguchi, N., Nabeshima, Y., & Noda, M. (2000) · Endocrinology · doi:10.1210/endo.141.1.7252 · Cited by 40 · see citing works

Estrogen Regulates Expression of Osteoprotegerin and RANKL in Human Periodontal Ligament Cells Through Estrogen Receptor Beta

Li, L., Yu, J., Wang, Y., & Ding, Y. (2008) · Journal of Periodontology · doi:10.1902/jop.2008.070437 · Cited by 38 · see citing works

Serum parathyroid hormone, but not menopausal status, is associated with the expression of osteoprotegerin and RANKL mRNA in human bone samples

Seck, T. L., Diel, I., Bismar, H., Ziegler, R., & Pfeilschifter, J. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450199 · Cited by 34 · see citing works

Long chain polyunsaturated fatty acids alter membrane-bound RANK-L expression and osteoprotegerin secretion by MC3T3-E1 osteoblast-like cells

Poulsen, R. C., Wolber, F. M., Moughan, P. J., & Kruger, M. C. (2007) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2007.10.004 · Cited by 33 · see citing works

The relationship between circulating osteoprotegerin levels and bone mineral metabolism in healthy women

Oh, K. W., Rhee, E., Lee, W., Kim, S. W., Oh, E. S., Baek, K. H., Kang, M. I., Choi, M. G., Yoo, H. J., & Park, S. W. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02090.x · Cited by 34 · see citing works

Increased bone resorption may play a crucial role in the occurrence of osteopenia in patients with type 2 diabetes: Possible involvement of accelerated polyol pathway in its pathogenesis

Takizawa, M., Suzuki, K., Matsubayashi, T., Kikuyama, M., Suzuki, H., Takahashi, K., Katsuta, H., Mitsuhashi, J., Nishida, S., Yamaguchi, S., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.07.008 · Cited by 31 · see citing works

In Vitro Generation of Mature Human Osteoclasts

Hemingway, F., Cheng, X., Knowles, H. J., Martínez, F. O., Gordon, S., & Athanasou, N. A. (2011) · Calcified Tissue International · doi:10.1007/s00223-011-9530-0 · Cited by 30 · see citing works

Unique and non-redundant function of csf1r paralogues in regulation and evolution of post-embryonic development of the zebrafish

Caetano‐Lopes, J., Henke, K., Urso, K., Duryea, J. W., Charles, J. F., Warman, M. L., & Harris, M. P. (2020) · Development · doi:10.1242/dev.181834 · Cited by 29 · see citing works

Bone formation in rabbit cancellous bone explant culture model is enhanced by mechanical load

ming, W. Z., Yu, L. J., xin, L. R., Hao, L., Yong, G., Liu, L., chang, Z. X., & Zhang, Z. (2013) · BioMedical Engineering OnLine · doi:10.1186/1475-925x-12-35 · Cited by 28 · see citing works

Osteoprotegerin Enhances Osteogenesis of Human Mesenchymal Stem Cells

Palumbo, S. L., & Li, W. (2013) · Tissue Engineering Part A · doi:10.1089/ten.tea.2012.0550 · Cited by 28 · see citing works

sRANKL/osteoprotegerin complex and biochemical markers in a cohort of male and female hemodialysis patients

Doumouchtsis, K., Kostakis, A., Doumouchtsis, S. K., Tziamalis, M. P., Tsigris, C., Kostaki, M., & Perrea, D. N. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03350814 · Cited by 25 · see citing works

Modulation of the Effects of Osteoprotegerin (OPG) Ligand in a Human Leukemic Cell Line by OPG and Calcitonin

Mancini, L., Moradi‐Bidhendi, N., Brandi, M. L., Perretti, M., & MacIntyre, I. M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3953 · Cited by 25 · see citing works

Osteoclastogenesis inhibitory factor/osteoprotegerin ameliorates the decrease in both bone mineral density and bone strength in immobilized rats.

Mochizuki, S.-I., Fujise, N., Higashio, K., & Tsuda, E. (2002) · Journal of Bone and Mineral Metabolism · doi:10.1007/s774-002-8441-x · Cited by 24 · see citing works

Native osteoprotegerin gene transfer inhibits the development of murine osteolytic bone disease induced by tumor xenografts.

Doran, P. M., Turner, R. T., Chen, D., Facteau, S. M., Ludvigson, J. M., Khosla, S., Riggs, B. L., & Russell, S. J. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.01.006 · Cited by 22 · see citing works

Osteoprotegerin

Feige, U. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.90003.iii81 · Cited by 21 · see citing works

Cathepsin K predicts femoral neck bone mineral density change in nonosteoporotic peri- and early postmenopausal women

Preželj, J., Ostanek, B., Logar, D. B., Marc, J., Hawa, G., & Kocjan, T. (2008) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181271873 · Cited by 20 · see citing works

Immunolocalization of CSF-1, RANKL and OPG in the enamel-related periodontium of the rat incisor and their implications for alveolar bone remodeling

Neves, J. D. S., Salmon, C. R., Omar, N. F., Narvaes, E. A. O., Gomes, J. R., & Novaes, P. D. (2009) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2009.04.001 · Cited by 20 · see citing works

Alteration of bone cell function by RANKL and OPG in different in vitro models

Lin, J., Callon, K. E., Lin, C. Q.-X., Bava, U., Zheng, M., Reid, I. R., & Cornish, J. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01800.x · Cited by 20 · see citing works

Localization of Osteoprotegerin (OPG) on Bone Surfaces and Cement Lines in Rat Tibia

Nakamura, H., Tsuji, T., Hirata, A., & Yamamoto, T. (2002) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540205000708 · Cited by 20 · see citing works

Is Heparin Effective for the Controlled Delivery of High-Dose Bone Morphogenetic Protein-2?

Kim, R. Y., Lee, B., Park, S.-N., Ko, J.-H., Kim, I. S., & Hwang, S. J. (2016) · Tissue Engineering Part A · doi:10.1089/ten.tea.2015.0537 · Cited by 19 · see citing works

Mutations within the TNF-Like Core Domain of RANKL Impair Osteoclast Differentiation and Activation

Cheng, T., Pavlos, N. J., Wang, C., Tan, J. W.-Y., Lin, J., Cornish, J., Zheng, M., & Xu, J. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0465 · Cited by 19 · see citing works

Isolation of Human Osteoclasts Formed In Vitro: Hormonal Effects on the Bone-Resorbing Activity of Human Osteoclasts

Kudo, O., Sabokbar, A., Pocock, A., Itonaga, I., & Athanasou, N. A. (2002) · Calcified Tissue International · doi:10.1007/s00223-001-2128-1 · Cited by 19 · see citing works

Breakthrough in bone: the molecular mechanism of osteoclast/osteoblast coupling revealed

Schwarz, E. M., & O’Keefe, R. J. (2000) · Current Opinion in Orthopedics · doi:10.1097/00001433-200010000-00001 · Cited by 17 · see citing works

Osteoprotegerin disrupts peripheral adhesive structures of osteoclasts by modulating Pyk2 and Src activities

Zhao, H., Liu, X., Zou, H., Dai, N., Yao, L., Zhang, X., Gao, Q., Liu, W. X., Gu, J., Yuan, Y., et al. (2016) · Cell Adhesion & Migration · doi:10.1080/19336918.2015.1129480 · Cited by 16 · see citing works

Inhibitory effects of osteoprotegerin on osteoclast formation and function under serum-free conditions

Fu, Y., Gu, J., Zhang, Y., Tong, X., Zhao, H., Yuan, Y., Liu, X., Bian, J., & Liu, Z. (2013) · Journal of Veterinary Science · doi:10.4142/jvs.2013.14.4.405 · Cited by 15 · see citing works

Hepatic osteodystrophy: Does the osteoprotegerin/receptor activator of nuclear factor-kB ligand systemplay a role?

Gaudio, A., Lasco, A., Morabito, N., Atteritano, M., Vergara, C., Catalano, A., Fries, W., Trifiletti, A., & Frisina, N. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03347549 · Cited by 15 · see citing works

Dexamethasone inhibits bone resorption by indirectly inducing apoptosis of the bone-resorbing osteoclasts via the action of osteoblastic cells

蕨, 信., Tachibana, Y., Kumegawa, M., & Hakeda, Y. (2001) · Cytotechnology · doi:10.1023/a:1008159332152 · Cited by 14 · see citing works

Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts

Hou, L., Hou, J., Yao, J., & Zhou, Z. (2011) · Acta veterinaria Scandinavica · doi:10.1186/1751-0147-53-21 · Cited by 14 · see citing works

The effects of lung and prostate cancer bone metastasis on serum osteoprotegerin levels: a meta-analysis

Zang, L., Ma, M., Hu, J., Qiu, H., Huang, B. S., & Chu, T. (2015) · Scientific Reports · doi:10.1038/srep18324 · Cited by 12 · see citing works

Cross-Talk between RANKL and FRP-1/CD98 Systems: RANKL-Mediated Osteoclastogenesis Is Suppressed by an Inhibitory Anti-CD98 Heavy Chain mAb and CD98-Mediated Osteoclastogenesis Is Suppressed by Osteoclastogenesis Inhibitory Factor

Mori, K., Miyamoto, N., Higuchi, Y., Nanba, K., Ito, M., Tsurudome, M., Nishio, M., Kawano, M., Uchida, A., & Ito, Y. (2001) · Cellular Immunology · doi:10.1006/cimm.2000.1748 · Cited by 12 · see citing works

Protein Kinase C Is a Mediator of the Synthesis and Secretion of Osteoprotegerin in Osteoblast-like Cells

Yang, X., Halladay, D., Onyia, J. E., Martin, T. J., & Chandrasekhar, S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6176 · Cited by 12 · see citing works

Involvement of the mitogen-activated protein kinase signaling pathway in osteoprotegerin-induced inhibition of osteoclast differentiation and maturation

Fu, Y., Gu, J., Wang, Y., Yuan, Y., Liu, X., Bian, J., & Liu, Z. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4284 · Cited by 10 · see citing works

Cytokines and Bone Remodeling

Mundy, G. R., Oyajobi, B. O., Traianedes, K., Dallas, S. L., & Chen, D. (2001) · Elsevier eBooks · doi:10.1016/b978-012470862-4/50014-3 · Cited by 8 · see citing works

Using the ratio of serum osteoprotegerin ligand to osteoprotegerin to evaluate renal osteodystrophy in dialysis patients.

Grzegorzewska, A. E., & Młot-Michalska, M. (2005) · PubMed · Cited by 7 · see citing works

Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro

Owen, S., Sanders, A. J., MASON, M. D., & Jiang, W. G. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3339 · Cited by 7 · see citing works

Serum markers of bone turnover in dialyzed patients separated according to age

Grzegorzewska, A. E., & Młot-Michalska, M. (2006) · International Urology and Nephrology · doi:10.1007/s11255-006-0079-1 · Cited by 7 · see citing works

A role for TNF in bone resorption of deciduous molars in human beings

Ureles, S. D., Chrzan, J. M., Norton, L. A., & Rossomando, E. F. (2000) · American Journal of Orthodontics and Dentofacial Orthopedics · doi:10.1067/mod.2000.105249 · Cited by 5 · see citing works

Association between circHIPK3/miR-378a-3p/HDAC4 axis and osteoporotic fractures: A comprehensive investigation

Wang, L., Sheng, Z., & Yao, T. (2023) · Journal of orthopaedic surgery · doi:10.1177/10225536231219637 · Cited by 3 · see citing works

Régulation ostéoblastique de la survie des ostéoclastes : effets du calcitriol

Mentaverri, R., Lorget, F., Wattel, A., Maamer, M., Kamel, S., & Brazier, M. (2000) · Comptes Rendus de l Académie des Sciences - Series III - Sciences de la Vie · doi:10.1016/s0764-4469(00)01249-x · Cited by 1 · see citing works

Effect of low intensity pulsed ultrasound (LIPUS) on bone healing around a titanium implant in the tibia of osteoporosis-induced rats

Hwang, Y.-S., Jeon, H.-J., Shin, S. H., Chung, I., Kim, G., Kim, C. H., & Kim, U. (2011) · 대한구강악안면외과학회지 · doi:10.5125/jkaoms.2011.37.5.386 · Cited by 1 · see citing works

The Effects of Osteoprotegerin Polymorphism on Bone Mineral Metabolism in Korean Women with Perimenopause

Oh, K. W., Yun, E. J., Rhee, E., Lee, W., Baek, K. H., Kang, M. I., Park, C., Ihm, S. H., Choi, M. G., Yoo, H. J., et al. (2005) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2005.20.3.204 · Cited by 1 · see citing works

Cytokines and Bone Remodeling

Mundy, G. R., Oyajobi, B. O., Gutierrez, G., Sterling, J. A. R., Padalecki, S. S., Elefteriou, F., & Zhao, M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375098-3.50019-6 · Cited by 1 · see citing works

The Immunologic Properties of Undifferentiated Stem Cells from Human Exfoliated Deciduous Teeth (SHED) and Its Potential Application in Bone Regeneration

Abdullah, D. N. A. (2013) · IIUM Medical Journal Malaysia · doi:10.31436/imjm.v12i1.1997 · Cited by 1 · see citing works

OPG, RANK and RANKL in Bone Metastasis and Cancer-Associated Osteolysis

Kostenuik, P. J. (2004) · Cancer metastasis · doi:10.1007/978-1-4020-2036-0_11 · Cited by 1 · see citing works

Receptor activator of nuclear factor кB ligand (RANKL) versus osteoprotegerin (OPG): the yin and yang of joint integrity

Bolon, B. N., Shalhoub, V., Kostenuik, P. J., Zack, D. J., & Feige, U. (2004) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7883-8_10

Bedeutung von RANK-Ligand und Osteoprotegerin für den Knochenstoffwechsel

Hofbauer, L. C., & Schoppet, M. (2006) · Springer eBooks · doi:10.1007/3-540-28782-5_21

Auswirkung von Bisphosphonaten auf die Expression von Osteoprotegerin (OPG) und Receptor activator of nuclear factor êB ligand (RANKL) in Osteoblastenkulturen aus Unterkiefer und Becken - Eine Pilotstudie am Hausschwein

Sievers, N. (2012) · doi:10.53846/goediss-1628

Análise da presença de citocinas no periodonto de ratos diabéticos tratados com chá verde

Gennaro, G. (2012) · doi:10.11606/t.25.2012.tde-04062013-100725

Muscular Strength Training Modifies Regulation of Bone Remodeling: Inferences from Serum Biomarkers in Young Women

Mardock, M. A. (2003) · VTechWorks (Virginia Tech)

In vitro and in vivo model systems used to assess bone-active factors

Cornish, J. (2000) · Bone · doi:10.1016/s8756-3282(00)80008-3

16. Lack of antagonist activity of melanocyte-stimulating hormone (MSH) on the actions of IL-1 on human bone-derived osteoblast-like cells

Evans, D., Thavarajah, M., & Kanis, J. A. (1991) · Bone · doi:10.1016/8756-3282(91)90112-v

Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i>¹

Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.-I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.3.5837 · Cited by 1,201 · see citing works

Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast.

Akatsu, T., Murakami, T., Nishikawa, M., Ono, K., Shinomiya, N., Tsuda, E., Mochizuki, S.-I., Yamaguchi, K., Kinosaki, M., Higashio, K., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9294 · Cited by 123 · see citing works

Osteoclastogenesis Inhibitory Factor (OCIF) の成熟破骨細胞への直接的な骨吸収活性抑制作用

小林, 之., 羽毛田, 慈., 山口, 京., 津田, 英., 東尾, 侃., 宮田, 隆., 山田, 多., & 久米川, 正. (1998) · Journal of Bone Metabolism